• 750+ attendees from bio/pharmaceutical companies,academic institutions and related industries
• Keynote session featuring Dr. Ron Mazumder, expert in biomarker and translational research
• High quality presentations focused on cancer immunotherapy, cell therapy and precision medicine
• Discussions about latest biopharmaceutical development policies and regulations
• 50+ service and product providers showcased the latest technologies in the field
• Designated space for 1:1 meeting connecting businesses with their clients
• BioPartnering Forum provided opportunities for talent recruitment and future collaborations
Innovative Therapy for Canner,What's Next?
New Technologies in Developing Biologic Drugs.
IP,Legal and Investment in Life Sciences.